Provided By PR Newswire
Last update: Jul 25, 2022
MILWAUKEE, July 25, 2022 /PRNewswire/ -- Ademi LLP is investigating Zymergen (NASDAQ: ZY) for possible breaches of fiduciary duty and other violations of law in its transaction with Ginkgo.
Read more at prnewswire.com